Clinical Trials Logo

Healthy clinical trials

View clinical trials related to Healthy.

Filter by:
  • Completed  
  • Page 1 ·  Next »

NCT ID: NCT04849962 Completed - Healthy Clinical Trials

Acute Consumption of Pecan-enriched Meal

Start date: August 10, 2017
Phase: N/A
Study type: Interventional

Pecans are a nutrient-dense food, but it is unknown whether substituting pecans for a portion of the butter in a traditional breakfast meal improves post-meal responses.

NCT ID: NCT04849949 Completed - Healthy Clinical Trials

Black Walnuts and Health

Start date: August 10, 2017
Phase: N/A
Study type: Interventional

Walnuts are a nutrient dense food, but most health research is on English walnuts (EW). Black walnuts (BW) contain a different antioxidant and fatty acid profile, and more protein, compared to EW. The purpose of the study was to compare postprandial responses following the consumption of 3 breakfast meals containing either butter (control), BW, or EW.

NCT ID: NCT04819581 Completed - Healthy Clinical Trials

Pharmacokinetic Study of SP-103 in Healthy Adult Human Subjects

Start date: August 3, 2019
Phase: Phase 1
Study type: Interventional

This study will assess the systemic exposure and pharmacokinetic parameters of SP-103 topical system following one, two, or three topical system applications and compare to the pharmacokinetics of ZTlido.

NCT ID: NCT04815460 Completed - Healthy Clinical Trials

Aerobic Interval and Moderate Continuous Exercise Training on Ventricular Functions

Start date: July 1, 2016
Phase: N/A
Study type: Interventional

Hypoxic exposure increases right ventricular (RV) afterload by triggering pulmonary hypertension, with consequent effects on the structure and function of the RV. Improved myocardial contractility is a critical circulatory adaptation to exercise training. However, the types of exercise that enhance right cardiac mechanics during hypoxic stress have not yet been identified. This study investigated how high-intensity interval training (HIIT) and moderate-intensity continuous training (MICT) influence right cardiac mechanics during hypoxic exercise (HE).

NCT ID: NCT04815395 Completed - Healthy Clinical Trials

Differential Effects of Oral and Intranasal Oxytocin on Attention Control

Start date: December 19, 2017
Phase: N/A
Study type: Interventional

The main aim of the present study is to investigate whether oxytocin (24IU) via different routes have divergent effects on attention control in a social-emotional saccade/antisaccade eye-tracking paradigm.

NCT ID: NCT04812301 Completed - Healthy Clinical Trials

Abbott Vital® as an Alternative Meal to the Gold-standard Egg-white Sandwich for Gastric Emptying Scintigraphy (GES)

Start date: March 17, 2021
Phase:
Study type: Observational

This crossover study is designed to compare the rates of gastric emptying between two diagnostic radioactive meals using the gold-standard egg-white sandwich meal and Abbott Vital®. Healthy participants will be recruited and randomly assigned into either groups of Abbott Vital® and gold-standard egg-white sandwich group. The measurements will be performed over a 4-hour period using a gamma camera, and estimated gastric emptying rates will be calculated using established algorithms.

NCT ID: NCT04811157 Completed - Healthy Clinical Trials

The Effect of Functional Dairy Products Enriched With Dietary Fibers on Human Health and Gut Microbiota

Start date: April 1, 2020
Phase: N/A
Study type: Interventional

The purpose of this dietary intervention is to study the effects of dietary fibers on the gut microbiota and use yoghurt as the carrier. Hypothesis 1: Intake of dietary fibers improves the blood lipid profile of the participants. Hypothesis 2: Intake of dietary fibers stabilizes the gut microbiome (e.g., low diversity) of the participants, improves gut health and normalizes gastrointestinal function and bowel habits.

NCT ID: NCT04805827 Completed - Healthy Clinical Trials

Comparative Randomized, Single Dose, Two-way Crossover Open-label Study to Determine the Bioequivalence of Gabapentin From Nerpentin 600 mg (Test ) F.C.T (Aman Pharma ,Egypt.) and Gabapentin From Neurontin 300 mg (Referance ) H.G.C. ( Pfizer Egypt)

Start date: February 25, 2021
Phase: N/A
Study type: Interventional

This study is conducted with the aim to investigate whether any differences concerning the rate and extent of absorption exist between the test and the reference product, Test product was Nerpentine 600 mg Film coated Tablet (Aman Pharma) Reference Product was Neurontin 300 mg Capsule.(Pfizer) The comparative bio availability of the two formulations was evaluated based in statistical comparisons of relevant pharmacokinetic parameters, obtained from data of drug concentrations in blood. Study was open-label, randomized, crossover, with 02 treatments, 02 sequences and 02 periods, under fasting conditions. one tablet from test product 600 mg against two capsules ( 2*300 mg ) reference product. Study population was 34 subjects , males ,adults between 18-55 years.

NCT ID: NCT04804657 Completed - Healthy Clinical Trials

Effects of Sage Extracts on Cognitive Function During Aerobic Exercise

Start date: February 1, 2021
Phase: N/A
Study type: Interventional

Extracts of sage have been reported to interact with central nervous system (CNS) mechanisms relevant to cognitive performance but, to date, no trial has clearly demonstrated the possible effects in healthy individuals in fatiguing conditions. The current study investigates the effects of this supplementation in healthy males and females versus placebo on cognition, heart rate and perceived exertion, during a fatiguing cycling exercise.

NCT ID: NCT04787952 Completed - Healthy Clinical Trials

Insight Into New Brown Adipose Tissue Activators.

Start date: October 1, 2016
Phase:
Study type: Observational

The general purpose of the study was to provide new information about the role of macronutrients intake, metabolomics, proteomics and microRNA on BAT activation. The invesigator evaluated BAT activity and whole body energy consumption under cold stimulation in two gruops of healthy males aged 21-43 years old with normal BMI ( 19-25kg/m2) and in overweight/obese subjects.